Review




Structured Review

Proimmune promix cmv peptide pool px-cmv
Promix Cmv Peptide Pool Px Cmv, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmv+peptides+promix+cmv+peptide+pool/promix+hcv+peptide+pool/pm40073016-249-34-25
Average 90 stars, based on 1 article reviews
promix cmv peptide pool px-cmv - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Cell Culture:

Article Title: Distinctive CD8 + T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells.
Article Snippet: Blood pDCs were enriched from fleshly isolated PBMCs by using negative magnetic selection, according to the manufacturer’s protocol (EasySep Human Plasmacytoid DC Enrichment kit, STEMCELL Technologies Cat#19062). .. To test if PBMC donors had CMV+ CD8+ T cells, 200,000 PBMCs were cultured in 200uL RF10 without stimulation (negative control), with 1 mg/mL CMV peptides (ProMix CMV Peptide Pool, ProImmune PX-CMV), and with 10 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich 79346) plus 0.5 mg/mL ionomycin (Sigma-Aldrich I9657) as positive control. .. Myeloid DCs were isolated from PBMCs using the EasySep humanmyeloid DC enrichment kit (Stemcell technologies cat #19061).

Negative Control:

Article Title: Distinctive CD8 + T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells.
Article Snippet: Blood pDCs were enriched from fleshly isolated PBMCs by using negative magnetic selection, according to the manufacturer’s protocol (EasySep Human Plasmacytoid DC Enrichment kit, STEMCELL Technologies Cat#19062). .. To test if PBMC donors had CMV+ CD8+ T cells, 200,000 PBMCs were cultured in 200uL RF10 without stimulation (negative control), with 1 mg/mL CMV peptides (ProMix CMV Peptide Pool, ProImmune PX-CMV), and with 10 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich 79346) plus 0.5 mg/mL ionomycin (Sigma-Aldrich I9657) as positive control. .. Myeloid DCs were isolated from PBMCs using the EasySep humanmyeloid DC enrichment kit (Stemcell technologies cat #19061).

Positive Control:

Article Title: Distinctive CD8 + T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells.
Article Snippet: Blood pDCs were enriched from fleshly isolated PBMCs by using negative magnetic selection, according to the manufacturer’s protocol (EasySep Human Plasmacytoid DC Enrichment kit, STEMCELL Technologies Cat#19062). .. To test if PBMC donors had CMV+ CD8+ T cells, 200,000 PBMCs were cultured in 200uL RF10 without stimulation (negative control), with 1 mg/mL CMV peptides (ProMix CMV Peptide Pool, ProImmune PX-CMV), and with 10 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich 79346) plus 0.5 mg/mL ionomycin (Sigma-Aldrich I9657) as positive control. .. Myeloid DCs were isolated from PBMCs using the EasySep humanmyeloid DC enrichment kit (Stemcell technologies cat #19061).



Similar Products

90
Proimmune promix cmv peptide pool px-cmv
Promix Cmv Peptide Pool Px Cmv, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmv+peptides+promix+cmv+peptide+pool/promix+hcv+peptide+pool/pm40073016-249-34-25
Average 90 stars, based on 1 article reviews
promix cmv peptide pool px-cmv - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Proimmune cmv peptides promix cmv peptide pool
Cmv Peptides Promix Cmv Peptide Pool, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmv+peptides+promix+cmv+peptide+pool/promix+hcv+peptide+pool/pm40073016-245-24-30
Average 90 stars, based on 1 article reviews
cmv peptides promix cmv peptide pool - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Proimmune cmv peptide pool promix tm
HSPC-pDCs have the capacity to adopt an antigen-presenting phenotype. a Expression levels of the indicated maturation APC markers on IFN-primed/unprimed HSPC-pDCs at day 21 + 3 <t>after</t> <t>stimulation</t> with the TLR7 agonist R837. b Graphical illustration of the experimental setup for T cell stimulatory capacity of HSPC-pDCs. HSPC-pDCs (IFN-primed and TLR7-activated) were pulsed with a mix of peptides derived from <t>CMV</t> (CMV ProMix) or left untreated (UT). After 3 h, cells were washed and co-cultured with allogeneic PBMCs harvested from CMV-seropositive donors and T cell activity was subsequently evaluated by measuring levels of IFN-γ in the supernatant 24 h later. c Levels of IFN-γ produced by PBMCs from three CMV-seropositive donors after co-culture with pDCs loaded with CMV ProMix. d Levels of IFN-γ produced by the same three PBMC donors mixed in a 10:1 ratio with three HSPC-pDC donors (IFN-primed and TLR7-activated) for 3 h with or without a pulse of CMV ProMix. e Blood pDCs or HSPC-pDCs were cultivated for 1, 3, 5, 8, and 12 days in medium supplemented with IL-3. At each time point, the viability was assessed by flow cytometry. f Comparison of area under curve of HSPC-pDCs and blood pDCs in the different conditions tested. Data shown are ±SEM of three ( a – d ) or four ( e – f ) donors. Statistical analysis was performed using regular two-way ANOVA ( e , f ) followed by Bonferroni post hoc test
Cmv Peptide Pool Promix Tm, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmv+peptides+promix+cmv+peptide+pool/promix+hcv+peptide+pool/pmc06117296-277-13-19
Average 90 stars, based on 1 article reviews
cmv peptide pool promix tm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Proimmune promix cmv peptide pool
KEY RESOURCES TABLE
Promix Cmv Peptide Pool, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmv+peptides+promix+cmv+peptide+pool/promix+hcv+peptide+pool/pmc05433942-17-0-5
Average 90 stars, based on 1 article reviews
promix cmv peptide pool - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Proimmune cmv pp65 peptide pool promix tm hcmva (pp65)
PBMCs were purified from the peripheral blood of young (age ≤ 40) and elderly (age ≥ 65) donors infected with <t>CMV</t> and stimulated for 6 hours with or without a CMV <t>pp65</t> peptide pool in the presence of Golgi plug during the last 5 hours of stimulation. Stimulated cells were fixed and permeabilized using appropriate buffers followed by staining with antibodies to CD3, CD8, IFN-γ and TNF-α (BD Pharmingen). Stained cells were analyzed on an LSRII® flow cytometer. (A) Representative data showing CD8+ T cells producing IFN-γ and/or TNF-α in response to CMV pp65 peptides. (B–E) The frequency of CD8+ T cells producing IFN-γ and/or TNF-α (B), IFN-γ only (C), TNF-α only (D) and both IFN-γ and TNF-α (E) in response to CMV pp65 peptides in young (n = 12) and elderly people (n = 14). Bars and error bars indicate mean and standard error of mean (SEM), respectively.
Cmv Pp65 Peptide Pool Promix Tm Hcmva (Pp65), supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmv+peptides+promix+cmv+peptide+pool/hla+a2+pp65+4+503+pentamer/pmc03563774-83-23-31
Average 90 stars, based on 1 article reviews
cmv pp65 peptide pool promix tm hcmva (pp65) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


HSPC-pDCs have the capacity to adopt an antigen-presenting phenotype. a Expression levels of the indicated maturation APC markers on IFN-primed/unprimed HSPC-pDCs at day 21 + 3 after stimulation with the TLR7 agonist R837. b Graphical illustration of the experimental setup for T cell stimulatory capacity of HSPC-pDCs. HSPC-pDCs (IFN-primed and TLR7-activated) were pulsed with a mix of peptides derived from CMV (CMV ProMix) or left untreated (UT). After 3 h, cells were washed and co-cultured with allogeneic PBMCs harvested from CMV-seropositive donors and T cell activity was subsequently evaluated by measuring levels of IFN-γ in the supernatant 24 h later. c Levels of IFN-γ produced by PBMCs from three CMV-seropositive donors after co-culture with pDCs loaded with CMV ProMix. d Levels of IFN-γ produced by the same three PBMC donors mixed in a 10:1 ratio with three HSPC-pDC donors (IFN-primed and TLR7-activated) for 3 h with or without a pulse of CMV ProMix. e Blood pDCs or HSPC-pDCs were cultivated for 1, 3, 5, 8, and 12 days in medium supplemented with IL-3. At each time point, the viability was assessed by flow cytometry. f Comparison of area under curve of HSPC-pDCs and blood pDCs in the different conditions tested. Data shown are ±SEM of three ( a – d ) or four ( e – f ) donors. Statistical analysis was performed using regular two-way ANOVA ( e , f ) followed by Bonferroni post hoc test

Journal: Nature Communications

Article Title: Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function

doi: 10.1038/s41467-018-05816-y

Figure Lengend Snippet: HSPC-pDCs have the capacity to adopt an antigen-presenting phenotype. a Expression levels of the indicated maturation APC markers on IFN-primed/unprimed HSPC-pDCs at day 21 + 3 after stimulation with the TLR7 agonist R837. b Graphical illustration of the experimental setup for T cell stimulatory capacity of HSPC-pDCs. HSPC-pDCs (IFN-primed and TLR7-activated) were pulsed with a mix of peptides derived from CMV (CMV ProMix) or left untreated (UT). After 3 h, cells were washed and co-cultured with allogeneic PBMCs harvested from CMV-seropositive donors and T cell activity was subsequently evaluated by measuring levels of IFN-γ in the supernatant 24 h later. c Levels of IFN-γ produced by PBMCs from three CMV-seropositive donors after co-culture with pDCs loaded with CMV ProMix. d Levels of IFN-γ produced by the same three PBMC donors mixed in a 10:1 ratio with three HSPC-pDC donors (IFN-primed and TLR7-activated) for 3 h with or without a pulse of CMV ProMix. e Blood pDCs or HSPC-pDCs were cultivated for 1, 3, 5, 8, and 12 days in medium supplemented with IL-3. At each time point, the viability was assessed by flow cytometry. f Comparison of area under curve of HSPC-pDCs and blood pDCs in the different conditions tested. Data shown are ±SEM of three ( a – d ) or four ( e – f ) donors. Statistical analysis was performed using regular two-way ANOVA ( e , f ) followed by Bonferroni post hoc test

Article Snippet: After 24 h stimulation, HSPC-pDCs were pulsed with 1 μg per peptide/mL of CMV (ProMix TM CMV Peptide Pool, ProImmune) or left untreated.

Techniques: Expressing, Derivative Assay, Cell Culture, Activity Assay, Produced, Co-Culture Assay, Flow Cytometry, Comparison

KEY RESOURCES TABLE

Journal: Cell host & microbe

Article Title: Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes which shapes the proviral landscape

doi: 10.1016/j.chom.2017.03.008

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: ProMix CMV Peptide Pool , ProImmune , PX-CMV.

Techniques: Functional Assay, Purification, Virus, Recombinant, Cell Isolation, Isolation, cDNA Synthesis, Amplification, Cloning, Enzyme-linked Immunosorbent Assay, Software

PBMCs were purified from the peripheral blood of young (age ≤ 40) and elderly (age ≥ 65) donors infected with CMV and stimulated for 6 hours with or without a CMV pp65 peptide pool in the presence of Golgi plug during the last 5 hours of stimulation. Stimulated cells were fixed and permeabilized using appropriate buffers followed by staining with antibodies to CD3, CD8, IFN-γ and TNF-α (BD Pharmingen). Stained cells were analyzed on an LSRII® flow cytometer. (A) Representative data showing CD8+ T cells producing IFN-γ and/or TNF-α in response to CMV pp65 peptides. (B–E) The frequency of CD8+ T cells producing IFN-γ and/or TNF-α (B), IFN-γ only (C), TNF-α only (D) and both IFN-γ and TNF-α (E) in response to CMV pp65 peptides in young (n = 12) and elderly people (n = 14). Bars and error bars indicate mean and standard error of mean (SEM), respectively.

Journal: Cytokine

Article Title: Maintenance of CMV-specific CD8 + T cell responses and the relationship of IL-27 to IFN-? levels with aging

doi: 10.1016/j.cyto.2012.11.024

Figure Lengend Snippet: PBMCs were purified from the peripheral blood of young (age ≤ 40) and elderly (age ≥ 65) donors infected with CMV and stimulated for 6 hours with or without a CMV pp65 peptide pool in the presence of Golgi plug during the last 5 hours of stimulation. Stimulated cells were fixed and permeabilized using appropriate buffers followed by staining with antibodies to CD3, CD8, IFN-γ and TNF-α (BD Pharmingen). Stained cells were analyzed on an LSRII® flow cytometer. (A) Representative data showing CD8+ T cells producing IFN-γ and/or TNF-α in response to CMV pp65 peptides. (B–E) The frequency of CD8+ T cells producing IFN-γ and/or TNF-α (B), IFN-γ only (C), TNF-α only (D) and both IFN-γ and TNF-α (E) in response to CMV pp65 peptides in young (n = 12) and elderly people (n = 14). Bars and error bars indicate mean and standard error of mean (SEM), respectively.

Article Snippet: To measure cytokine production by CMV-specific CD8 + T cells, PBMCs from CMV-positive individuals were stimulated for 6 hours with or without a CMV pp65 peptide pool (ProMix TM HCMVA (PP65), Proimmune, Sarasota, FL) in the presence of Golgi plug (BD Pharmingen, San Diego, CA) during the last 5 hours of stimulation.

Techniques: Purification, Infection, Staining, Flow Cytometry

PBMCs were purified from the peripheral blood of young (age ≤ 40) and elderly (age ≥ 65) donors infected with CMV and stained with CFSE. Stained cells were stimulated for 7 days with or without a CMV pp65 peptide pool. Cell proliferation was analyzed on an LSRII® flow cytometer. (A) Representative data showing CD8+ T cell proliferation in response to CMV pp65 peptides. (B) The frequency of CD8+ T cells that proliferated in response to CMV pp65 peptides in young (n = 11) and elderly (n =15) people. Bars and error bars indicate mean and SEM, respectively. (C–D) Correlation of the frequencies of proliferating and cytokine producing CD8+ T cells in young and elderly people. P values were obtained using the unpaired t-test (B) and the Pearson correlation analysis (C–D).

Journal: Cytokine

Article Title: Maintenance of CMV-specific CD8 + T cell responses and the relationship of IL-27 to IFN-? levels with aging

doi: 10.1016/j.cyto.2012.11.024

Figure Lengend Snippet: PBMCs were purified from the peripheral blood of young (age ≤ 40) and elderly (age ≥ 65) donors infected with CMV and stained with CFSE. Stained cells were stimulated for 7 days with or without a CMV pp65 peptide pool. Cell proliferation was analyzed on an LSRII® flow cytometer. (A) Representative data showing CD8+ T cell proliferation in response to CMV pp65 peptides. (B) The frequency of CD8+ T cells that proliferated in response to CMV pp65 peptides in young (n = 11) and elderly (n =15) people. Bars and error bars indicate mean and SEM, respectively. (C–D) Correlation of the frequencies of proliferating and cytokine producing CD8+ T cells in young and elderly people. P values were obtained using the unpaired t-test (B) and the Pearson correlation analysis (C–D).

Article Snippet: To measure cytokine production by CMV-specific CD8 + T cells, PBMCs from CMV-positive individuals were stimulated for 6 hours with or without a CMV pp65 peptide pool (ProMix TM HCMVA (PP65), Proimmune, Sarasota, FL) in the presence of Golgi plug (BD Pharmingen, San Diego, CA) during the last 5 hours of stimulation.

Techniques: Purification, Infection, Staining, Flow Cytometry